BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma
This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI)
First received: September 13, 2001
Last updated: February 8, 2013
Last verified: April 2008
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Estimated Study Completion Date:||No date given|
|Primary Completion Date:||August 2003 (Final data collection date for primary outcome measure)|
Brinker BT, Krown SE, Lee JY, Cesarman E, Chadburn A, Kaplan LD, Henry DH, Von Roenn JH. Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium. Cancer. 2008 Mar 1;112(5):1083-8. doi: 10.1002/cncr.23108.